Should I Order a PET Scan? Integrating Molecular Imaging into Urologic Oncology Clinical Practice: Current Approaches and Future Opportunities (2026) CME Available: https://cme.auanet.org/URL/26DC041ONL LEARNING OBJECTIVES: At the conclusion of this activity, participants will be able to: 1. Analyze the best available evidence on the current diagnostic imaging options for prostate, kidney, bladder, and testis cancer detection, staging, and follow-up. 2. Describe the benefits of combined functional and anatomic information gained through accurate matching of anatomic (CT/MRI) and functional (PET) images. 3. Debate the strengths and limitations of emerging molecular imaging techniques compared to existing diagnostic tests. 4. Optimally stage urologic oncology patients by understanding the performance characteristics of standard and emerging molecular imaging modalities. 5. Define the emerging role of PET imaging and novel radiotracers to assess chemotherapy and immunotherapy response. 6. Formulate a strategic plan for appropriate integration of molecular imaging into clinical practice. ACKNOWLEDGEMENTS: Support provided by independent educational grants from: Astellas Lantheus Medical Imaging Novartis Pharmaceuticals Corporation Pfizer, Inc

AUA Guidelines: Advanced Prostate Cancer
4 views

Capitol Stream: Advancing Men’s Health on Capitol Hill
7 views

AUA2026: Focus on: Metastatic Urothelial Carcinoma (mUC)
92 views

Use of Ambient Listening AI Scribes: Improved Wellness and Efficiency in the Outpatient Setting
48 views

Global Perspectives: Lessons in Innovation, Resourcefulness, and Collaboration from Brazil
29 views

AUA Guidelines: Clinically Localized Prostate Cancer
292 views